There are many kinds of drugs for the treatment of prostate cancer, the commonly used ones in clinic are androgen receptor inhibitors, depot drugs and androgen synthesis inhibitors, among which abiraterone, enzalutamide, goserelin and so on are the newest drugs, which have good effect in clinic, and the specific classification is as follows: 1. Androgen receptor inhibitors: the first generation of androgen receptor inhibitors are mainly non-steroidal anti-androgen drugs, including bicalutamide, flutamide, etc. The second generation of androgen receptor inhibitors include enzalutamide, darotamide, etc., which can inhibit the binding of androgens to their receptors, inhibit the activity of androgen receptor, and thus achieve the effect of inhibiting the growth of tumor cells. 2. Deleterious drugs: including two kinds of drugs, one is gonadotropin-releasing hormone agonist represented by goserelin, and the other one is gonadotropin-releasing hormone antagonist represented by degarelix, such drugs can inhibit the release of testosterone and reduce the concentration of testosterone. 3. Androgen synthesis inhibitor: it can inhibit the key enzyme of androgen synthesis to inhibit androgen secretion from adrenal glands, prostate glands and testosterone, and the representative drug is abiraterone. It is suggested that patients should consult the doctor in time, and should not use drugs blindly on their own to avoid delaying or aggravating the condition.